pi3k (Proteintech)
Structured Review

Pi3k, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 315 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+pi3k/PI3K+p85+alpha+Antibody/pmc13011214-154-45-72
Average 96 stars, based on 315 article reviews
Images
1) Product Images from "PKA and PKC signaling pathways mediate vitamin D₃-regulated intestinal phosphorus absorption in broiler chickens"
Article Title: PKA and PKC signaling pathways mediate vitamin D₃-regulated intestinal phosphorus absorption in broiler chickens
Journal: Poultry Science
doi: 10.1016/j.psj.2026.106762
Figure Legend Snippet: Effects of dietary vitamin D 3 supplementation on jejunal phosphorylation levels of PKA, PKC, PI3K, p38MAPK, and ERK in broiler chickens (19 d) (Experiment 1). The control and vitamin D 3 diets contained 0 and 1000 IU/kg vitamin D 3 , respectively. (a) p-PKA/t-PKA; (b) p-PKC/t-PKC; (c) p-PI3K/t-PI3K; (d) p-p38MAPK/t-p38MAPK; (e) p-ERK/t-ERK. Protein abundance values are means ± SD of four replicates per treatment (1 broiler per replicate) (n = 4). Values with different letters differ between treatments ( P < 0.05).
Techniques Used: Phospho-proteomics, Control, Quantitative Proteomics
Figure Legend Snippet: Effects of the PKA inhibitor H-89 on jejunal phosphorylation levels of PKC, PI3K, p38MAPK, and ERK in broiler chickens (10–15 d) (Experiment 2). (a) p-PKC/t-PKC; (b) p-PI3K/t-PI3K; (c) p-p38MAPK/t-p38MAPK; (d) p-ERK/t-ERK. Protein abundance values are means ± SD of four replicates per treatment (1 broiler per replicate) (n = 4). Values with different letters differ between treatments ( P < 0.05).
Techniques Used: Phospho-proteomics, Quantitative Proteomics
Figure Legend Snippet: Effects of the PKC inhibitor staurosporine on duodenal phosphorylation levels of PKA, PI3K, p38MAPK, and ERK in broiler chickens (13 d) (Experiment 3). (a) p-PKA/t-PKA; (b) p-PI3K/t-PI3K; (c) p-p38MAPK/t-p38MAPK; (d) p-ERK/t-ERK. Protein abundance values are means ± SD of four replicates per treatment (1 broiler per replicate) (n = 4). Values with different letters differ between treatments ( P < 0.05).
Techniques Used: Phospho-proteomics, Quantitative Proteomics
Related Articles
Incubation:Article Title: TRIM21-Mediated ubiquitination of FBL suppresses PI3K/AKT signaling and tumor progression in clear cell renal cell carcinoma. Article Snippet: .. Membranes were blocked with 5% nonfat milk for 1 h at room temperature and incubated overnight at 4 ° C with the following primary antibodies: anti-FBL (Proteintech, Cat# 66985-1-Ig), anti-Trim21 (Proteintech, Cat# 12108-1-AP), Article Title: Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway Article Snippet: .. Membranes were blocked with QuickBlockTM Western Blocking Reagent (P0252, Beyotime, Foshan, Guangdong, China) for 15 min at room temperature, followed by incubation with the following primary antibodies at 4 °C overnight: anti-E-cadherin (1:1000; 28731-1-AP), anti-CXCR4 (1:1000; 11073-2-AP), anti-Akt (1:1000; 10176-2-AP), anti-p-Akt (1:1000; 28731-1-AP), anti-MMP9 (1:1000; 10375-2-AP), anti-GAPDH (1:1000; 10494-1-AP), anti-BAX (1:1000; 50599-2-Ig), anti-BCL-2 (1:1000; 12789-1-AP), anti-caspase-9 (1:1000; 10380-1-AP), Article Title: TRIM21-Mediated ubiquitination of FBL suppresses PI3K/AKT signaling and tumor progression in clear cell renal cell carcinoma Article Snippet: .. Membranes were blocked with 5% nonfat milk for 1 h at room temperature and incubated overnight at 4 °C with the following primary antibodies: anti-FBL (Proteintech, Cat# 66985-1-Ig), anti-Trim21 (Proteintech, Cat# 12108-1-AP), Article Title: Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway. Article Snippet: .. Membranes were blocked with QuickBlockTM Western Blocking Reagent (P0252, Beyotime, Foshan, Guangdong, China) for 15 minutes at room temperature, followed by incubation with the following primary antibodies at 4 °C overnight: anti-E-cadherin (1:1000; 28731-1-AP), anti-CXCR4 (1:1000; 11073-2-AP), anti-Akt (1:1000; 10176-2-AP), anti-p-Akt (1:1000; 28731- 1-AP), anti-MMP9 (1:1000; 10375-2-AP), anti-GAPDH (1:1000; 10494-1-AP), anti-BAX (1:1000; 50599-2-Ig), antiBCL-2 (1:1000; 12789-1-AP), anti-caspase-9 (1:1000; 10380-1-AP), Control:Article Title: TRIM21-Mediated ubiquitination of FBL suppresses PI3K/AKT signaling and tumor progression in clear cell renal cell carcinoma. Article Snippet: .. Membranes were blocked with 5% nonfat milk for 1 h at room temperature and incubated overnight at 4 ° C with the following primary antibodies: anti-FBL (Proteintech, Cat# 66985-1-Ig), anti-Trim21 (Proteintech, Cat# 12108-1-AP), Article Title: TRIM21-Mediated ubiquitination of FBL suppresses PI3K/AKT signaling and tumor progression in clear cell renal cell carcinoma Article Snippet: .. Membranes were blocked with 5% nonfat milk for 1 h at room temperature and incubated overnight at 4 °C with the following primary antibodies: anti-FBL (Proteintech, Cat# 66985-1-Ig), anti-Trim21 (Proteintech, Cat# 12108-1-AP), Western Blot:Article Title: Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway Article Snippet: .. Membranes were blocked with QuickBlockTM Western Blocking Reagent (P0252, Beyotime, Foshan, Guangdong, China) for 15 min at room temperature, followed by incubation with the following primary antibodies at 4 °C overnight: anti-E-cadherin (1:1000; 28731-1-AP), anti-CXCR4 (1:1000; 11073-2-AP), anti-Akt (1:1000; 10176-2-AP), anti-p-Akt (1:1000; 28731-1-AP), anti-MMP9 (1:1000; 10375-2-AP), anti-GAPDH (1:1000; 10494-1-AP), anti-BAX (1:1000; 50599-2-Ig), anti-BCL-2 (1:1000; 12789-1-AP), anti-caspase-9 (1:1000; 10380-1-AP), Article Title: Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway. Article Snippet: .. Membranes were blocked with QuickBlockTM Western Blocking Reagent (P0252, Beyotime, Foshan, Guangdong, China) for 15 minutes at room temperature, followed by incubation with the following primary antibodies at 4 °C overnight: anti-E-cadherin (1:1000; 28731-1-AP), anti-CXCR4 (1:1000; 11073-2-AP), anti-Akt (1:1000; 10176-2-AP), anti-p-Akt (1:1000; 28731- 1-AP), anti-MMP9 (1:1000; 10375-2-AP), anti-GAPDH (1:1000; 10494-1-AP), anti-BAX (1:1000; 50599-2-Ig), antiBCL-2 (1:1000; 12789-1-AP), anti-caspase-9 (1:1000; 10380-1-AP), Blocking Assay:Article Title: Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway Article Snippet: .. Membranes were blocked with QuickBlockTM Western Blocking Reagent (P0252, Beyotime, Foshan, Guangdong, China) for 15 min at room temperature, followed by incubation with the following primary antibodies at 4 °C overnight: anti-E-cadherin (1:1000; 28731-1-AP), anti-CXCR4 (1:1000; 11073-2-AP), anti-Akt (1:1000; 10176-2-AP), anti-p-Akt (1:1000; 28731-1-AP), anti-MMP9 (1:1000; 10375-2-AP), anti-GAPDH (1:1000; 10494-1-AP), anti-BAX (1:1000; 50599-2-Ig), anti-BCL-2 (1:1000; 12789-1-AP), anti-caspase-9 (1:1000; 10380-1-AP), Article Title: Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway. Article Snippet: .. Membranes were blocked with QuickBlockTM Western Blocking Reagent (P0252, Beyotime, Foshan, Guangdong, China) for 15 minutes at room temperature, followed by incubation with the following primary antibodies at 4 °C overnight: anti-E-cadherin (1:1000; 28731-1-AP), anti-CXCR4 (1:1000; 11073-2-AP), anti-Akt (1:1000; 10176-2-AP), anti-p-Akt (1:1000; 28731- 1-AP), anti-MMP9 (1:1000; 10375-2-AP), anti-GAPDH (1:1000; 10494-1-AP), anti-BAX (1:1000; 50599-2-Ig), antiBCL-2 (1:1000; 12789-1-AP), anti-caspase-9 (1:1000; 10380-1-AP), |



